#Recherche #Biotech Biogen, Sobi share phase 3 results of haemophilia A drug - http://t.co/Y7jJztqLbU
July 05, 2013
Publicité
/http%3A%2F%2Fwww.pharmaphorum.com%2Fimages%2Fbanners%2FMusculoskeletal_disorders_focus.jpg)
Biogen, Sobi share phase 3 results of haemophilia A drug
Biogen, Sobi share phase 3 results of haemophilia A drug - News Biogen and the rare disease pharma company, Swedish Orphan Biovitrum AB (publ) (Sobi), have announced that the results of a phase 3 clinical trial support the clinical and safety profile of t